Deriving HEALTH-BASED EXPOSURE LIMITS in the PHARMACEUTICAL INDUSTRY.

Autor: WEIDEMAN, P., Bercu, J. P., Callis, C., Lilly, Eli, Dolan, D. G., Faria, E., Flueckiger, A., Gould, J., Hayes, E. P., Jolly, R., Barle, E. Lovsin, Luo, W., Molnar, L. R., Morinello, E., Naumann, B. D., Olson, M., Pfister, T., Sandhu, R., Sargent, E. V., Seaman, C.
Zdroj: Contract Pharma; Sep2015, Vol. 17 Issue 7, p74-80, 6p
Abstrakt: The article offers information on a workshop related to harmonization of acceptable daily exposures and permitted daily exposures (ADE/PDE) derivation and application that was held in New York in October 2014.
Databáze: Complementary Index